Windlas Biotech Ltd Board Approves Buyback of Shares Worth Up to INR 47 Crore
Windlas Biotech Ltd announced that its Board of Directors approved a buyback of its fully paid-up equity shares. The resolution, passed at a meeting held on April 17, 2026, outlines the terms for repurchasing a specified portion of its equity capital.The Board approved a buyback of up to 4,70,000 fully paid-up equity shares, each having a face value of INR 5.00. This buyback represents 2.23% of the company's total existing paid-up equity share capital. The maximum potential value of the buyback is set at INR 47,00,00,000, representing 9.80% of the aggregate of the total paid-up equity share capital and free reserves (including securities premium) as of March 31, 2025.
The buyback will be executed at a price of INR 1,000 per equity share, payable in cash. The repurchase will be made from all eligible shareholders, excluding the promoters and members of the promoter group, through a Tender Offer route.
Key Buyback Parameters
The transaction details are summarized below:| Parameter | Details |
|---|---|
| Maximum Shares to be Bought Back | 4,70,000 Equity Shares |
| Face Value per Share | INR 5.00 |
| Maximum Buyback Value | INR 47,00,00,000 |
| Buyback Price | INR 1,000 per equity share (in cash) |
| Percentage of Total Equity | 2.23% |
| Exclusions | Buyback size excludes transaction costs, brokerage, fees, taxes, and related expenses. |
The Board determined that the record date for ascertaining shareholder eligibility for the buyback is set as April 24, 2026.
The company also confirmed that the proportion of shares entitled to small shareholders, as per the shareholding on the Record Date, or the number of shares proposed for buyback, whichever is higher, shall be reserved for them.
Shareholding Structure
The pre-buyback shareholding pattern of Windlas Biotech Ltd as of March 31, 2026, is detailed as follows:| Shareholder Category | No. of Shareholders | No. of Equity Shares Held | % of Shareholding |
|---|---|---|---|
| Promoters & Promoter Group | 7 | 1,30,65,352 | 61.9% |
| Mutual Funds | 4 | 14,94,421 | 7.08% |
| Alternative Investment Funds | 9 | 9,96,857 | 4.72% |
| NBFCs registered with RBI | 1 | 450 | 0% |
| Foreign Portfolio Investors | 25 | 1,25,885 | 0.6% |
| Directors and their relatives (excluding independent and nominee directors) | 1 | 23,533 | 0.11% |
| Key Managerial Personnel | 2 | 33,443 | 0.16% |
| Resident Individuals (up to Rs. 2 lakhs) | 42,408 | 41,11,525 | 19.48% |
| Resident Individuals (in excess of Rs. 2 lakhs) | 3 | 3,72,034 | 1.76% |
| Non-Resident Indians (NRIs) | 788 | 2,89,720 | 1.37% |
| Bodies Corporate | 153 | 2,69,143 | 1.28% |
| Others | 1,368 | 3,23,866 | 1.53% |
| Total | 44,769 | 2,11,06,229 | 100% |
The company confirmed that the post-buyback shareholding pattern shall be determined upon the completion of the transaction.
The Board also constituted a buyback committee to oversee the process and appointed Fintellectual Corporate Advisors Private Limited, a SEBI Registered Merchant Banker, as the Manager for the buyback.
WINDLAS Stock Price Movement
As of 2:05 PM, shares of Windlas Biotech Limited are shedding 2.61% in live trading, currently positioned at ₹848.05. The equity tumbled ₹22.75, with the stock seeing a notable total traded volume of 52,013 shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.